Quick Links

Contact Us

Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.

Authors: Robert A Kloner

Journal: Circulation

Publication Type: Journal Article

Date: 2004

DOI: 10.1161/01.CIR.0000146906.42375.D3

ID: 15533876

Affiliations:

Affiliations

    Heart Institute, Good Samaritan Hospital, and the Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles 90017, USA. rkloner@goodsam.org

Chemical List

    Adrenergic alpha-Antagonists|||Carbolines|||Imidazoles|||Nitric Oxide Donors|||Phosphodiesterase Inhibitors|||Piperazines|||Purines|||Sulfones|||Triazines|||Vasodilator Agents|||Vardenafil Dihydrochloride|||Tadalafil|||Sildenafil Citrate|||Phosphoric Diester Hydrolases|||3',5'-Cyclic-GMP Phosphodiesterases|||Cyclic Nucleotide Phosphodiesterases, Type 5|||PDE5A protein, human|||Nitroglycerin|||Cyclic GMP|||Isosorbide Dinitrate|||isosorbide-5-mononitrate